Welcome to LookChem.com Sign In|Join Free
  • or
N-cyclobutylMethanesulfonamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1075233-88-3

Post Buying Request

1075233-88-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1075233-88-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1075233-88-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,5,2,3 and 3 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1075233-88:
(9*1)+(8*0)+(7*7)+(6*5)+(5*2)+(4*3)+(3*3)+(2*8)+(1*8)=143
143 % 10 = 3
So 1075233-88-3 is a valid CAS Registry Number.

1075233-88-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name N-cyclobutylmethanesulfonamide

1.2 Other means of identification

Product number -
Other names cyclobutyl carbinylsulfonamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1075233-88-3 SDS

1075233-88-3Downstream Products

1075233-88-3Relevant academic research and scientific papers

Hepatitis C virus inhibitors

-

, (2008/06/13)

The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.

Hepatitis C virus inhibitors

-

, (2008/06/13)

The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1075233-88-3